Treatment results in patients with acute myocardial infarction with ST-segment elevation at the Uppersilesian Cardiology Center in Katowice;Wyniki leczenia chorych z zawałem serca z uniesieniem odcinka st w górnośla̧skim ośrodku kardiologii w katowicach

Kardiologia Polska

Volumn 58, Issue SUPPL. 4, 2003, Pages

  Maślankiewicz, Katarzyna ^a   Jaklik, Andrzej ^b   Jakubowski, Daniel ^b   Kośmider, Jerzy ^b   Ochała, Andrzej ^b   Skowerski, Mariusz ^b   Wita, Krystian ^b   Wȩglarz, Przemysław ^b   Zaorski, Krzysztof ^b   Buszman, Paweł ^b   Drzewiecki, Janusz ^b   Ga̧sior, Zbigniew ^b   Gross, Maria ^b   Trusz Gluza, Maria ^b   Tendera, Michał ^b  

^a AM   (Poland)

^b NONE

Author keywords

Mortality; Myocardial infarction; PTCA; Shock

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CORONARY STENT; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 17444433298     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sadanandan S., Hochman J.S.: Early reperfusion, late reperfusion and the open artery hypothesis: an overview. Prog. Cardiovasc. Dis. 2000, 42, 397-404.
2. Lieu T.A., Gurley R.J., Lundstrom R.J. i wsp.: Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J. Am. Coll. Card. 1996, 27, 737-750.
3. Hannan E.L., Racz M.J., Djavad T.A. i wsp.: Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J. Am. Coll. Card. 2000, 36, 1194-1201.
4. Vogt A., Niederer W., Pfafferott C. i wsp.: Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction. Eur. Heart J. 1998, 19, 917-921.
5. Antoniucci D., Santoro G., Bolognese L. i wsp.: A clinical trial comparing primary stenting of the infant-related artery with optima primary angioplasty for acute myocardial infarction. FRESCO Trial. J. Am. Coll. Card. 1998, 31, 1234-1239.
6. Rajendra H.M., Bates E.R.: Coronary stent implantation in acute myocardial infarction. Am. Heart J. 1999, 137, 603-611.
7. Montalescot G., Barragan P., Wittenberg O. i wsp.: Platelet glycoprotein IIB/IIIA inhibition with coronary stenting for acute myocardial infarction. N. Engl. J. Med. 2001, 344, 1895-1903.
8. Berger P.B., Ellis S.G., Holmes D.R. i wsp.: Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Results from GUSTO-IIb Trial. Circulation 1999, 100, 14-20.
9. Goldberg R.J., Gore J.M., Thompson CA. i wsp.: Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: The second National Registry of Myocardial Infarction. Am. Heart J. 2001, 141, 65-72.
10. Carnendran L., Abboud R., Sleeper L.A. i wsp.: Trends in cardiogenic shock: report from the SHOCK study. Eur. Heart J. 2001, 22, 472-478.
11. Urban P., Stauffer J.C., Bleed D. i wsp.: A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (S)MASH Trial. Eur. Heart J. 1999, 20, 1030-1038.
12. Hochman J.S., Sleeper L.A., Webb J.G. i wsp.: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N. Engl. J. Med. 1999, 341, 625-634.